Entecavir
22 NDCs across 11 manufacturers|20 Generic,2 Brand
Entecavir is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 29, 2005, and the first generic was approved Aug 26, 2014. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $30 million on Entecavir across 133,000 claims for 26,000 beneficiaries.
Entecavir is available as 22 NDCs from 11 manufacturers (20 generic, 2 brand), with NADAC prices from $0.22 to $44.19 per EA — the most expensive product costs about 202× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
22
20G / 2B
Manufacturers
11
competing in market
Price Spread
$0.22 – $44.19
per EA
7d Activity
avg +1.7% WoW · of 22 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing ENTECAVIR(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BARACLUDE 0.5 MG TABLET | $44.1865 per EA | — |
BARACLUDE 1 MG TABLET | $43.9221 per EA | — |
ENTECAVIR 0.5 MG TABLET | $1.4828 per EA | — |
ENTECAVIR 0.5 MG TABLET | $1.0765 per EA | — |
ENTECAVIR 1 MG TABLET | $0.7163 per EA | — |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 1 MG TABLET | $0.3684 per EA | +0.73% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
ENTECAVIR 0.5 MG TABLET | $0.2186 per EA | +2.41% |
Frequently Asked Questions
What is Entecavir used to treat?
Entecavir is used to treat chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
When did Entecavir become available as a generic?
FDA approved the first generic Entecavir (ANDA) on Aug 26, 2014. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Entecavir?
In 2024, Medicare Part D spent $30 million on Entecavir across 133,000 claims for 26,000 beneficiaries.
How many Entecavir products are on the market?
The Entecavir drug market contains 22 NDCs from 11 manufacturers — 20 generic and 2 brand products.
What is the price range for Entecavir?
NADAC reference prices for Entecavir range from $0.2186 to $44.1865 per EA — the most expensive product costs about 202× the cheapest.
Is generic Entecavir cheaper than brand?
The average generic NADAC for Entecavir is $0.4020 per EA, versus $44.0543 for brand-labeled products — brand versions average about 110× the generic price.
Which manufacturers make Entecavir?
11 manufacturers list Entecavir in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (3), Camber Pharmaceuticals Inc. (3), E.R. Squibb & Sons, L.L.C. (2), Amneal Pharmaceuticals LLC (2), Epic Pharma LLC (2).
How has the price of Entecavir changed recently?
Over the past 7 days, 17 Entecavir NDCs rose and 0 fell, with a market-wide average change of +1.7%.